Navigation Links
Peregrine Pharmaceuticals Awarded Second Broad U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
Date:11/4/2009

TUSTIN, Calif., Nov. 4 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHMD) today announced that the U.S. Patent and Trademark Office has issued U.S. Patent Number 7,611,704, which includes broad claims covering anti-viral uses of phosphatidylserine (PS)-targeting antibodies including Peregrine's lead clinical compound, bavituximab. PS is a unique marker exposed on the surface of virally infected cells that can be targeted to treat a broad spectrum of virus infections.

The new patent covers compositions and methods of treating virus infections using bavituximab and similar antibodies, either alone or as immunoconjugates attached to anti-viral agents, as well as in combination with other anti-viral agents. The breadth of the claims in the new patent is especially noteworthy since it includes methods for treating all viruses in humans and in animals. The therapeutic potential of these antibodies is supported by data in a landmark study published in the December 2008 edition of Nature Medicine showing that bavituximab and other PS-targeting antibodies have the potential to cure lethal virus infections across a broad range of virus families in animal disease models.

"This broad anti-viral patent further expands our intellectual property leadership in the field of PS-targeting antibodies at a time when our anti-viral program is experiencing a rising tide of interest and activity," said Steven W. King, president and CEO of Peregrine. "We are especially pleased at the scope of the issued claims in this new patent, which covers the use of bavituximab and similar antibodies in the treatment of any and all virus infections. Antibodies falling under the scope of this new patent have already demonstrated promising anti-viral activity in clinical trials in patients with hepatitis C virus (HCV) infection an
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Regains Full Compliance With Nasdaq Continued Listing Requirements
2. Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer
3. Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
4. Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations
5. Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara(R) for Treatment of Brain Cancer
6. Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials
7. Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients
8. Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies
9. Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrines Fully Human Anti-PS Antibody in Prostate Cancer Model
10. Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrines PS-Targeting Antibodies
11. Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Champions Biotechnology, Inc . (OTC Bulletin Board: CSBR), ... preclinical platforms and tumor specific data to enhance ... financial results for the second fiscal quarter ended ... financial results are available in the Company,s Form ... for the second quarter of 2010 were $1,289,000 ...
(Date:12/15/2009)... newly formed industry, community and education initiative to advance ... is working to connect the orthopedics capital of the ... high-speed rail. ,, In a September report, ... World -- An overview, analysis and blueprint for ... statewide initiative to grow Indiana,s unique life sciences assets, ...
(Date:12/15/2009)... researchers with EDP Biotech Corporation (EDP) have captured ... a simple blood test to detect early-stage colon ... its pre-clinical trials for the ColoMarker(TM) assay, EDP ... and all aspects of its use. Via ... cancer in its earliest, most curable stages. ,, ...
Breaking Medicine Technology:Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 2Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 3Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 4Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 5OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 2OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 3Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2Free Online Tools Benefitting Time Starved Cost Conscious Home Cooks 54709 1Free Online Tools Benefitting Time Starved Cost Conscious Home Cooks 54709 2Inc Magazine Names Enovate as One of the Fastest Growing Private Companies in the US 54707 1Inc Magazine Names Enovate as One of the Fastest Growing Private Companies in the US 54707 2Inc Magazine Names Enovate as One of the Fastest Growing Private Companies in the US 54707 3H1N1 Flu 28Swine Flu 29 Fears What People Can Do to Ease Them According to GLT Enviro 54703 1H1N1 Flu 28Swine Flu 29 Fears What People Can Do to Ease Them According to GLT Enviro 54703 2H1N1 Flu 28Swine Flu 29 Fears What People Can Do to Ease Them According to GLT Enviro 54703 3
... Marks Major Corporate Milestone and Advances ... Clinical ... today announced the approval of its second investigational new drug,(IND) application ... Company,s aromatase inhibitor (AI), in combination with,estrogen and progestin for the ...
... non-small, cell lung cancer patients receiving Tavocept in conjunction with standard ... ... of 6.5 months seen for patients with ... SAN ANTONIO, July 17 BioNumerik Pharmaceuticals, Inc.,("BioNumerik") today announced that ...
Other Medicine Technology:Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis 2Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis 3Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis 4BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial 2BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial 3BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial 4
(Date:12/15/2009)... CITY, Dec. 15 The new compact LifeSpan ... ( www.LifeSpanFitness.com ), was highly praised by ... treadmills for 2010. The compact TR200 folding treadmill received ... Best Treadmill under $1000. ,, The compact LifeSpan ... in small workout spaces. "This category buster is a ...
(Date:12/15/2009)... new study links chronic obstructive pulmonary disease, or COPD, ... to activate the body,s immune system. , The ... growing awareness of the immune system,s role in COPD, ... 12 million Americans with wheezing, shortness of breath, chest ... if doctors are to find better ways to detect ...
(Date:12/15/2009)... combined with developmental changes increases risk in teens, study ... teenagers, being overweight or obese increases the risk of ... to be true for younger children, Australian researchers have ... children, aged 2 to 18, who were referred for ... researchers found that among those aged 12 and older ...
(Date:12/15/2009)... for injury when doctors decide benefits of imaging outweigh ... MRI scans can pose a serious risk to people ... Drug Administration researchers exposed pacemakers to a simulated MRI ... at the tip of the pacemaker lead, where it ... The exposure to MRI magnetic pulses caused certain pacemakers ...
(Date:12/15/2009)... NEW YORK, Dec. 15 ... research report is available in its ... Manufacturing Industry in the U.S. and ... ,, http://www.reportlinker.com/p0167482/In-Vitro-Diagnostic-Substance-Manufacturing-Industry-in-the-US-and-its-International-Trade-[Q4-2009-Edition].html ,, ... Manufacturing Industry report provides the latest ...
Breaking Medicine News(10 mins):Health News:Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill 2Health News:Immune cell activity linked to worsening COPD 2Health News:Immune cell activity linked to worsening COPD 3Health News:Puberty May Trigger Sleep Apnea in Overweight Kids 2Health News:Patients With Pacemakers Should Avoid MRI Scans 2Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 2Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 3Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 4Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 5Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 6Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 7Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 8
... for action from ICANN, US-based domain ... ... an,online pharmacy verification service, and KnujOn.com, an Internet spam and,criminality watchdog, ... illicit sale of anabolic steroids., Steroid abuse is part of ...
... form of non-Hodgkin disease puts older men chiefly at ... News) -- The prevalence of mantle cell lymphoma, an ... patients are diagnosed with advanced stages of the disease, ... Texas M.D. Anderson Cancer Center. , Mantle cell ...
... July 18 In the last ten years over 360,children ... an average of 36,per year, according to a study by ... video from General Motors (NYSE: GM ) at:, http://media.medialink.com/WebNR.aspx?story=35362 ... many parents are,unaware of how dangerous a car can become ...
... Up For, WASHINGTON, July 18 Last week, ... that America,s,economic problems were "psychological" by saying Americans are ... "nation of whiners." While McCain,distanced himself from Gramm at ... top economic adviser. Now, John McCain is in Michigan, ...
... awareness campaign to raise awareness, of the importance ... ... Md., July 18 The COSHAR Foundation, a,nonprofit organization dedicated ... and disadvantaged populations, hosts,National Women,s Health Awareness Day on Saturday, ...
... ... in Texas, TYLER, Texas, July 18 Patients ... among the first,in the nation to have access to ... for a wide variety of cancers., (Logo: ...
Other Medicine News:Health News:Kids at Risk: Report Identifies 150 Websites Selling Anabolic Steroids 2Health News:Incidence of Mantle Cell Lymphoma on Rise 2Health News:DNC: McCain Watch: The Economy 2Health News:DNC: McCain Watch: The Economy 3Health News:The COSHAR Foundation Participates in Annual Women's Health Awareness Day 2Health News:The COSHAR Foundation Participates in Annual Women's Health Awareness Day 3Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 2Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 3Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 4Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 5
The Surgifresh mini has the same rugged construction as the Plume-inator. It is the ideal size for operating room, clinic and office settings. This unit includes a filter test button, hospital grade ...
A system for the removal and filtration of laser and surgical smoke....
The FreedomAire Surgical Helmet System is a lightweight, comfortable helmut system with superior air flow, and a removable motor module that lifts off for easy cleaning....
...
Medicine Products: